您的位置: 首页 > 农业专利 > 详情页

METHODS FOR TREATING CANCER AND PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS
专利权人:
LiPlasome Pharma ApS
发明人:
Knudsen, Steen,Jensen, Peter Buhl,Buhl, Ulla Hald,Rasmussen, Annie,Madsen, Mogens Winkel
申请号:
AU2019200325
公开号:
AU2019200325A1
申请日:
2019.01.18
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
#$%^&*AU2019200325A120190815.pdf#####METHODS FOR TREATING CANCER AND PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS 5 ABSTRACT Featured are methods of treating a patient with cancer by administering, e.g., a secretory phospholipase A2 (sPLA2) hydrolysable, cisplatin-containing liposome composition (e.g., LiPlaCis). The patient may be assessed for their responsiveness to the liposomal therapy prior to treatment using the 0 methods, devices, and kits also described herein for detecting a level of one or more biomarkers in a sample from the patient with cancer. 106
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充